May 3, 2012 (Chicago, Illinois) — The second-generation GTS400 stent has a high intraoperative reliability, and appears to be safe and effective, with a postoperative decrease in intraocular pressure ...

CORONADO, California — Trabecular micro-bypass stents reduce intraocular pressure in glaucoma patients just as well as the prostaglandin analog travoprost, according to a new study. Although ...

Micro eye stent developer Glaukos has filed to raise up to $86 million in an IPO to advance an already marketed product, as well as to further develop three additional ones in its pipeline. In the ...

OSN Glaucoma Board Member Ike K. Ahmed, MD, FRCSC, said he considers micro-stent procedures to be safer than other tube shunt devices or trabeculectomy. “They are procedurally very efficient, less ...

Allergan has been aggressively pursuing treatments for “underserved” eye diseases, shelling out hundreds of millions on a pair of glaucoma device makers in the past 18 months. Now, its bet on a gel ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--AqueSys, Inc., the developer of minimally invasive stent technology for the treatment of glaucoma, announced today it will host a XEN Gel Stent Symposium at the 6 ...

(HealthDay News) – An ocular stent that’s designed to reduce inner-eye pressure among people with mild or moderate open-angle glaucoma has been approved by the US Food and Drug Administration. The ...

FDA has announced it has approved the first glaucoma stent for use with cataract surgery, according to a news release. The iStent Trabecular Micro-Bypass Stent System, model GTS100R/L, manufactured by ...

Betty Fecteau, left, 85, of West Seneca, had a tiny stent surgically placed into her right eye in May by Dr. Paul C. Holmwood, right, an ophthalmologist with Eye Care & Vision Associates, which has ...

ZURICH (Reuters) - Novartis' eye care unit Alcon is withdrawing a surgical stent for glaucoma patients after clinical data showed it may damage the eye, but the Swiss drugmaker said the move would not ...

NEW YORK (CBSNewYork) --A tiny new device could help prevent a leading cause of blindness. The glaucoma implant is the size of a human hair, and was just approved by the Food and Drug Administration.

Please provide your email address to receive an email when new articles are posted on . Through an evolution that has seen several prototypes enter and leave the scene, ultra-small drainage devices ...